Open Access

Beneficial effects of varicocele embolization on semen parameters

  • Julie Prasivoravong1, 7Email author,
  • François Marcelli1,
  • Laurent Lemaître2,
  • Pascal Pigny3,
  • Nassima Ramdane4,
  • Marie-Claire Peers5,
  • Valérie Mitchell5, 6 and
  • Jean-Marc Rigot1, 6
Basic and Clinical Andrology201424:9

https://doi.org/10.1186/2051-4190-24-9

Received: 10 February 2014

Accepted: 28 April 2014

Published: 16 May 2014

Abstract

Background

The value of varicocele repair and the latter's impact on semen parameters are still subject to debate.

Methods

We analyse changes over time in initially abnormal sperm parameters and serum concentrations of testosterone, FSH and inhibin B after embolization treatment of males with high-grade varicocele. From 2007 to 2012, we recruited 47 male infertile patients with clinically visible left varicocele in the resting patient and at least one abnormal semen parameter. Sperm parameters and serum levels of total testosterone, FSH and inhibin B were measured prior to retrograde embolization (M0) and then 3 (M3) and 6 (M6) months afterwards.

Results

At M0, the median sperm concentration was 5.78 [0.84-37.70] × 106/ejaculate. The mean ± SD sperm progressive motility, vitality and percentage of normal sperm were respectively, 21.83 ± 16.48%, 61.88 ± 15.98% and 12.88 ± 7.15%. The corresponding values at M3 were significantly higher (38.75 [3.96-95] × 106/ejaculate, 29.32 ± 14.21%, 69.14 ± 14.86% and 19.03 ± 11.02%, respectively). The mean percentage of spermatozoa with a thin head was significantly lower at M6 (6.35 ± 5.29%) than at M0 (14.03 ± 13.09%). The mean serum testosterone, FSH and inhibin B levels did not change significantly over time.

Conclusions

Embolization treatment in men with clinically visible left varicocele, abnormal sperm parameters and documented infertility is associated with a significant improvement in semen parameters including sperm head morphology.

Varicocele Sperm parameters FSH Inhibin B Embolization

Résumé

Introduction

L’intérêt du traitement de la varicocèle clinique et son impact sur les paramètres spermatiques sont de nos jours toujours débattus.

Méthodes

Nous avons analysé l’évolution dans le temps des paramètres spermatiques et les concentrations sériques de testostérone, FSH et inhibine B d’hommes infertiles ayant une varicocèle de haut grade traitée par embolisation rétrograde. De 2007 à 2012, 47 patients ayant une varicocèle clinique de grade 3 et au moins un paramètre de sperme anormal ont été recrutés. Les paramètres spermatiques et les taux de testostérone totale, de FSH et d'inhibine B sérique ont été mesurés avant embolisation (M0) et 3 (M3) et 6 (M6) mois après embolisation.

Résultats

La numération spermatique médiane initiale de la population était de 5,78 [0,84-37,70] × 106 /éjaculat. Les moyennes ± déviation standard de la mobilité progressive, la vitalité et le pourcentage de spermatozoïdes normaux étaient respectivement de 21,83 ± 16,48%, 61,88 ± 15,98% et 12,88 ± 7,15%. A M3, les valeurs étaient significativement plus élevées (38,75 [3,96-95] × 106/éjaculat, 29,32 ± 14,21%, 69,14 ± 14,86% et 19,03 ± 11,02% respectivement). Le pourcentage moyen de spermatozoïdes à tête amincie était significativement plus faible à M6 (6,35 ± 5,29%) qu’à M0 (14,03 ± 13,09%). Les taux sériques moyens de la testostérone, FSH et inhibine B étaient comparables tout au long de la prise en charge des patients.

Conclusion

L'embolisation de la varicocèle de haut grade chez les hommes ayant au moins un paramètre spermatique anormal est associée à une amélioration significative des paramètres spermatiques et notamment des spermatozoïdes à tête amincie.

Varicocèle Paramètres spermatiques FSH Inhibine B Embolisation

Background

Varicocele is characterized by abnormal tortuosity and dilatation of the veins of the pampiniform plexus within the spermatic cord. The frequency of varicocele can be as high as 22% in the general population and 15% in adolescents [1]. Forty per cent of men with an abnormal semen analysis have varicocele [1]. In 1955, Tulloch reported on a link between varicocele repair and male fertility for the first time [2]. The relevance of varicocele repair in assisted reproductive technologies is still subject to debate because of the divergence in research findings [35]. The choice of the technique for varicocele repair and the procedure's impact on semen quality parameters are also much debated. An optimal treatment technique would be associated with the lowest possible recurrence and complication rates. Semen analysis is widely used as a marker of spermatogenesis. Despite heterogeneity in patient characteristics, diagnostic criteria, treatment methods and treatment outcomes, most researchers have found that varicocele repair is associated with a significant improvement in the sperm concentration (in 15 out of 22 studies) and progressive motility (in 12 out of 17 studies) [4]. Varicocele repair's effect on sperm morphology is less clear [68] and it has been suggested that significant morphological changes in germ cells can only be observed over long follow-up periods [7]. Menkveld et al. [9] showed that the measurement or evaluation of sperm morphology remains therefore a very important tool in the diagnosis of a male’s fertility potential and in the clinical decision making for the treatment of patients with infertility problems. Varicocele also affects hormonal status. Serum FSH and inhibin B levels are widely accepted markers of a patient's spermatogenic status. However, there is controversy over the nature and significance of serum hormone levels (and particularly inhibin B levels) after varicocele repair [1012].

The aim of the present study was to analyse changes over time in initially abnormal sperm parameters (concentration, motility, vitality and morphology) and serum concentrations of testosterone, FSH and inhibin B after embolization treatment in males with high-grade varicocele.

Methods

Inclusion criteria

Male outpatients were recruited by the Department of Andrology at Lille University Hospital between March 2007 and June 2012, according to the French Urology Society's criteria for varicocele and male infertility [1]: documented infertility for more than 1 year, clinically visible left varicocele in the resting patient (i.e. grade III [1]) and at least one abnormal semen parameter in the initial semen analysis (according to the 2010 WHO criteria) [13]: a sperm concentration <39 × 106/ejaculate and a percentage of progressive motility a + b <32%). Sperm morphology was assessed according to David’s modified classification [14] and the lower reference value for normal sperm was set to 15%.

Scrotal ultrasonography

Varicocele was confirmed by scrotal ultrasonography in standing and supine patients and during the Valsalva manoeuvre. Varicocele was defined as a maximum vein diameter >3 mm and vein reflux > 2 seconds. The testicular volume (defined as 0.71 × length × width × height) was measured with an iStyle SSA 790A ultrasound system (Toshiba, Tochigi, Japan). The normal total (right plus left) testicular volume was defined as 32 mL or more [15].

Hormonal status

Serum levels of total testosterone, FSH and inhibin B were assayed in blood samples drawn in the morning (8 to 10 AM) before embolization (M0) and then 3 (M3) and 6 (M6) months thereafter. Serum testosterone was measured in a radioimmunoassay (Coat-A-Count, Siemens, Los Angeles, CA, USA). The reference range was taken as 2.30–6.0 ng/mL [16]. Serum FSH levels were determined in an immunoassay (Abbott, Longford, Republic of Ireland) with a limit of detection of 0.05 IU/L and intra and interassay coefficients of variation below 3%. The reference range was 1.23-7.89 IU/L [17]. Serum inhibin B levels were measured using the two-site OBI Inhibin B enzyme immunoassay (Oxford Bio-Innovation Ltd, Oxford, UK). To improve the measurement range, an additional reference point (7.8 pg/mL) was added to the standard curve [16]. The mean normal serum inhibin B concentration was taken as 105–439 pg/mL [17].

Semen samples

Sperm analyses were performed in the Biology of Reproduction Unit at Lille University Hospital. Samples were obtained by masturbation after 2–5 days of sexual abstinence. After liquefaction, standard semen parameters (volume, concentration, motility and vitality, i.e. the percentage of live spermatozoa) were measured according to the 2010 WHO guidelines [13]. Semen analyses were performed twice prior to embolization (M0) (to confirm the semen parameters) and then 3 and 6 months afterwards (M3 and M6, respectively).

Intervention: left embolization

All procedures were performed by the same radiologist (LL). In a prior consultation, the radiologist confirmed the indication for embolization and provided the patient with information about the procedure. Embolization was performed with the retrograde approach. The patient lay supine on a movable table (Axiom M, Siemens, Munich, Germany). After induction of local anaesthesia (xylocaine, 200 mg/20 mL), the right femoral vein was punctured with an 18G needle. Under fluoroscopic guidance, a 5 F introducer sheath (Desilet 4 F Radifocus, Terumo, Tokyo, Japan) was placed in the access site to avoid injury of the vein. A hydrophilic guide (Wire M, Terumo, Leuven, Belgium) and a 4 F angiographic catheter (C2 4 F 60 cm 38”, Cordis, Hialeah FL, USA) were then advanced to gain access to the internal spermatic vein via the inferior vena cava and the left renal vein. While the patient was in a semi-upright position, contrast medium was injected manually in order to acquire a retrograde venogram of the testicular vein as far down as the pampiniform plexus (Figure 1). We used Tornado® embolization coils (Cook Medical, Bloomington, IN, USA) (Figure 2) or AMPLATZER™ plugs (St Jude Medical, Saint Paul, MN, USA) to occlude the testicular vein and any collateral venous channels responsible for reflux. A venogram of the left iliac vein was acquired after embolization of the left testicular vein, in order to check for successful embolization and the lack of aberrant drainage pathways (Figure 3). Successful embolization was defined as the absence of contrast medium above the inserted coil or plug.
Figure 1

A retrograde venogram of the testicular vein before embolization.

Figure 2

An X-ray showing embolization coils occluding the testicular vein.

Figure 3

A post-embolization venogram showing the retention of contrast medium upstream of the coils.

Data analyses

All statistical analyses were performed with SAS software (version 9.2, SAS Institute Inc., Cary, NC, USA). Depending on the data distribution, the results were expressed as the mean ± standard deviation (SD) or the median [interquartile range]. The normality of the data distribution was tested in a Shapiro-Wilk test. Longitudinal data were evaluated with an analysis of variance for repeated measures. Comparisons at each time point were performed using post hoc tests with a Bonferroni correction. The threshold for statistical significance (notably when defining a significant pre- vs. post- embolization improvement in sperm parameters) was set to p < 0.05.

Results

During the study period, 119 patients with varicocele were referred to our andrology clinic for the assessment of fertility problems. A total of forty seven infertile patients (mean ± SD age: 30.43 ± 5.16; mean duration of infertility: 33.76 ± 19.72 months) underwent embolization for grade III varicocele of the left testis and were thus included in the study. The mean left testicular volume was 12.67 ± 4.21 mL and the mean total (right plus left) testicular volume was 28.69 ± 9.49 mL. All 47 embolization procedures were technically successful, as confirmed by a venogram showing the absence of contrast medium above the inserted coil or plug. At M0, the mean serum testosterone, FSH and inhibin B levels were 4.61 ± 1.38 ng/mL, 8.91 ± 5.94 IU/L and 122.7 ± 83.84 pg/mL, respectively (Table 1). There were no significant changes over time (i.e. from M0 to M3 and then M6) in any of these levels.
Table 1

Semen parameters and hormone levels before embolization (M0) and 3 and 6 months afterwards (M3 and M6, respectively)

n=47 patients

M0

M3

M6

pvalue

Testosterone ng/mL

4.61 ± 1.38 (4.42) [3.65-5.55]

4.49 ± 1.43 (4.14) [3.38-5.52]

4.92 ± 2.17 (4.64) [3.54-5.50]

1a 0.58b 0.08c

FSH IU/L

8.91 ± 5.94 (7.65) [4.35-11.95]

8.40 ± 4.99 (7.60) [4.40-11.50]

8.11 ± 4.88 (7.30) [4.60-10.70]

0.24a 0.18b 1c

Inhibin B pg/mL

122.7 ± 83.84 (107) [69-170]

131 ± 86.99 (111) [64.5-170]

131.7 ± 79.86 (113.5) [84-171]

1a 1b 1c

Spermatozoa 106/ejaculate

28.44 ± 55.99 (5.78) [0.84-37.70]

52.59 ± 55.51 (38.75) [3.96-95]

55.19 ± 70.53 (21.75) [4.41-85.05]

<0.0003a 0.0036b 1c

% progressive motility

21.83 ± 16.48 (18.5) [8-35]

29.32 ± 14.21 (30) [20-37.50]

29.19 ± 17.84 (25) [15-40]

0.0086a 0.0093b 1c

% vitality

61.88 ± 15.98 (65.5) [52-74]

69.14 ± 14.86 (70) [61.50-80] 2

67.05 ± 17.10 (72) [60-80] 2

0.02a 0.18b 1c

% typical spermatozoa

12.88 ± 7.15 (12) [8-18.50]

19.03 ± 11.02 (16) [10-28]

19.11 ± 10.74 (17) [10-26]

0.0001a 0.0002b 1c

% thin head

14.03 ± 13.09 (10) [5-16]

9.26 ± 8.69 (7) [3-13]

6.35 ± 5.29 (4) [4-7]

0.05a 0.01b 1c

Multiple Anomalies Index

1.88 ± 0.19 (1.87) [1.75-1.98]

1.79 ± 0.23 (1.79) [1.63-1.90]

1.78 ± 0.27 (1.69) [1.59-1.96]

0.04a 0.24b 1c

Values are the mean ± SD (median) [1st quartile- 3rd quartile]. aM0 vs. M3; bM0 vs. M6; cM3 vs. M6.

A sperm concentration below 39×106 spermatozoa per ejaculate was observed in 36 of the 47 patients (77%). Asthenozoospermia (progressive motility a + b less than 32%) was observed in 31 of the 47 patients (65%). Twenty-two of the 47 patients (46%) had fewer than 15% of typical sperm cells.

The median sperm concentration per ejaculate at M3 (38.75 [3.96-95] × 106/ejaculate) was significantly higher (p < 0.05) than the value at M0 (5.78 [0.84-37.70] × 106/ejaculate). Similarly, the mean sperm progressive motility at M3 (29.32 ± 14.21%) was significantly greater value at M0 (21.83 ± 16.48%). This was also the case of mean vitality (69.14 ± 14.86% at M3, up from 61.88 ± 15.98% at M0). There were no significant changes in sperm concentration, progressive motility or vitality when comparing M3 with M6.

The mean percentage of normal sperm at M3 (19.03 ± 11.02%) was significantly greater than the value at M0 (12.88 ± 7.15%). The mean percentage of sperm with an abnormally thin head was significantly lower at M6 (6.35 ± 5.29%) than at M0 (14.03 ± 13.09%). The mean multiple anomalies index at M3 (1.79 ± 0.23) was significantly lower than at M0 (1.88 ± 0.19) decreased to. There were no significant changes in sperm morphology, thin head anomalies or the multiple anomalies index when comparing M3 with M6.

Discussion

Men from infertile couples should be appropriately counselled on the likelihood of attaining a significant improvement in semen parameters after varicocele repair. Divergent results have been obtained when the efficacy criterion is an improvement in sperm morphology. The effect of varicocele repair on sperm head and flagella parameters is less clear. Some researchers have reported a significant increase in the percentage of spermatozoa with a normal morphology [6, 18, 19]. In contrast, Gazzera et al. [7] did not observe any significant differences in sperm morphology. The initial (and now dated) study by Czyglik et al. [20] showed an increase in the proportion of spermatozoa with an abnormally thin head. Osawa et al. [21] showed that low ICSI fertilisation rates have also been found in men with severely elongated spermatozoa compared to other morphology abnormalities. Here, we provide evidence to show that embolization is associated with a significant decrease in the proportion of spermatozoa with an abnormally thin head.

In an analysis of 9038 men at 34 centers in 24 countries, the World Health Organisation study showed that varicocele is clearly associated with infertility and impaired testicular function [22]. Although this topic has been extensively investigated since then, a variety of conclusions were reached because the physiopathology of varicocele is not completely understood. Hypotheses concerning the harmful effects of varicocele [23] include scrotal/testicular hyperthermia, elevations in serum gonadotropin levels, increased venous pressures, the accumulation of toxins, hypoxia, and hormonal imbalance. The effects of the correction of varicocele on sperm quality and reproductive potential are less well understood. Clinical research has demonstrated improved semen parameters, higher DNA integrity, and better assisted reproductive technology outcomes after varicocele repair [24].

Treatment options for varicocele can be divided into two major categories [25, 26]: (i) percutaneous occlusion via intravenous injection of various materials (embolization or sclerotherapy) and (ii) surgical ligation or clipping to prevent venous reflux, e.g. open surgical varicocelectomy (inguinal, subinguinal or retroperitoneal approaches), laparoscopic varicocelectomy and microsurgical (inguinal or subinguinal) varicocelectomy. Embolization presents several advantages: ambulatory management, the requirement for local anaesthesia only, low cost, a low failure rate (for experienced radiologists) and a low complication rate. Dewire et al. [27] showed that percutaneous embolization is equally effective in improving male fertility and costs about the same as the surgical ligature of varicocele.

Varicocele in infertile men is generally associated with Leydig cell dysfunction and hypogonadism. It has been shown that varicocelectomy significantly increases serum testosterone levels in men with hypogonadism and infertility [28, 29]. In the present study, spermatogenesis was not strongly altered and our patients did not have severe oligoasthenoteratozoospermia. We did not observe significant changes over time in serum testosterone, FSH and inhibin B concentrations. Inhibin B is an important factor in testicular hormonal function. In men with severe oligoasthenoteratozoospermia, treatment of varicocele was associated with a significant increase in inhibin B levels and a significant decrease in FSH levels [8]. Some researchers have noted a significant improvement in serum inhibin B level after varicocelectomy and have concluded that combining this endocrine marker with a spermogram could be an effective guide to the effect of varicocelectomy on spermatogenesis [12, 30]. In contrast, our present results confirmed those of Fujisawa et al. [11], in which the preoperative serum inhibin B concentration did not reliably predict the response to varicocelectomy. This discrepancy may be due to the fact that the inhibin B level was in the normal range in our study population, which suggesting that there were no major Sertoli cell disorders. This hypothesis fits with the relatively normal FSH levels observed here. In the present study, the biological presentation of men with varicocele was heterogeneous. The results of the World Health Organisation study [22] showed that clinically confirmed left varicocele was associated with a relatively small left testis. Many other studies have evidenced a relationship between testicular volume and varicocele in infertile patients [31, 32]. Our patients displayed scrotal hypotrophy but were not hypogonadal according to clinical biochemistry parameters. Furthermore, we did not observe significant changes in hormonal parameters after embolization.

Conclusions

The present study results show that varicocele embolization (a well-tolerated technique with a high benefit-cost ratio) in men with grade III left varicocele, abnormal sperm parameters and documented infertility in the couple is associated with a significant improvement in sperm concentration, motility, vitality and morphology but not in serum testosterone, FSH and inhibin B levels. This finding supports suggestions that varicocele impairs spermatogenesis but not the testicles’ steroidogenic function. The present study was limited by the absence of data on pregnancy rates. More detailed studies are therefore required before firm conclusions on the prognosis for fertility can be drawn.

Declarations

Authors’ Affiliations

(1)
Department of Andrology, Lille University Hospital
(2)
Department of Radiology, Lille University Hospital
(3)
Department of Biochemistry and Molecular Biology, Lille University Hospital
(4)
Department of Biostatistics, Lille University Hospital
(5)
Biology of Reproduction Unit, Lille University Hospital
(6)
EA4308 Gametogenesis and Gamete Quality, University of Lille
(7)
Department of Andrology, CHRU Lille, Hôpital Calmette, Boulevard du Professeur Leclercq

References

  1. Wagner L, Tostain J: [Varicocele and male infertility: AFU 2006 guidelines]. Prog En Urol J Assoc Fr Urol Société Fr Urol. 2007, 17: 12-17.View ArticleGoogle Scholar
  2. TULLOCH WS: Varicocele in subfertility; results of treatment. Br Med J. 1955, 2: 356-358. 10.1136/bmj.2.4935.356.PubMed CentralView ArticlePubMedGoogle Scholar
  3. Agarwal A, Deepinder F, Cocuzza M, Agarwal R, Short RA, Sabanegh E, Marmar JL: Efficacy of varicocelectomy in improving semen parameters: new meta-analytical approach. Urology. 2007, 70: 532-538. 10.1016/j.urology.2007.04.011.View ArticlePubMedGoogle Scholar
  4. Baazeem A, Belzile E, Ciampi A, Dohle G, Jarvi K, Salonia A, Weidner W, Zini A: Varicocele and male factor infertility treatment: a new meta-analysis and review of the role of varicocele repair. Eur Urol. 2011, 60: 796-808. 10.1016/j.eururo.2011.06.018.View ArticlePubMedGoogle Scholar
  5. Nevoux P, Mitchell V, Chevallier D, Rigot J-M, Marcelli F: Varicocele repair: does it still have a role in infertility treatment? Curr Opin Obstet Gynecol. Curr Opin Obstet Gynecol. 2011, 23: 151-157. 10.1097/GCO.0b013e32834552d7.View ArticlePubMedGoogle Scholar
  6. Galfano A, Novara G, Iafrate M, De Marco V, Cosentino M, D’Elia C, Artibani W, Ficarra V: Improvement of seminal parameters and pregnancy rates after antegrade sclerotherapy of internal spermatic veins. Fertil Steril. 2009, 91: 1085-1089. 10.1016/j.fertnstert.2008.01.040.View ArticlePubMedGoogle Scholar
  7. Gazzera C, Rampado O, Savio L, Di Bisceglie C, Manieri C, Gandini G: Radiological treatment of male varicocele: technical, clinical, seminal and dosimetric aspects. Radiol Med (Torino). 2006, 111: 449-458. 10.1007/s11547-006-0041-4.View ArticleGoogle Scholar
  8. Ghanem MA, Safan MA, Ghanem AA, Dohle GR: The role of varicocele sclerotherapy in men with severe oligo-astheno-teratozoospermia. Asian J Androl. 2011, 13: 867-871. 10.1038/aja.2011.48.PubMed CentralView ArticlePubMedGoogle Scholar
  9. Menkveld R, Holleboom CAG, Rhemrev JPT: Measurement and significance of sperm morphology. Asian J Androl. 2011, 13: 59-68. 10.1038/aja.2010.67.PubMed CentralView ArticlePubMedGoogle Scholar
  10. Di Bisceglie C, Bertagna A, Baldi M, Lanfranco F, Tagliabue M, Gazzera C, Gandini G, Manieri C: Varicocele sclerotherapy improves serum inhibin B levels and seminal parameters. Int J Androl. 2007, 30: 531-536. 10.1111/j.1365-2605.2007.00747.x.View ArticlePubMedGoogle Scholar
  11. Fujisawa M, Dobashi M, Yamasaki T, Kanzaki M, Okada H, Arakawa S, Kamidono S: Significance of serum inhibin B concentration for evaluating improvement in spermatogenesis after varicocelectomy. Hum Reprod Oxf Engl. 2001, 16: 1945-1949. 10.1093/humrep/16.9.1945.View ArticleGoogle Scholar
  12. Pierik FH, Abdesselam SA, Vreeburg JT, Dohle GR, De Jong FH, Weber RF: Increased serum inhibin B levels after varicocele treatment. Clin Endocrinol (Oxf). 2001, 54: 775-780. 10.1046/j.1365-2265.2001.01302.x.View ArticleGoogle Scholar
  13. WHO: WHO laboratory manual for the examination and processing of human semen [Internet]. 2012, WHO, http://www.who.int/reproductivehealth/publications/infertility/9789241547789/en/index.html,Google Scholar
  14. Auger J, Eustache F, Ducot B, Blandin T, Daudin M, Diaz I, Matribi SE, Gony B, Keskes L, Kolbezen M, Lamarte A, Lornage J, Nomal N, Pitaval G, Simon O, Virant-Klun I, Spira A, Jouannet P: Intra- and inter-individual variability in human sperm concentration, motility and vitality assessment during a workshop involving ten laboratories. Hum Reprod Oxf Engl. 2000, 15: 2360-2368. 10.1093/humrep/15.11.2360.View ArticleGoogle Scholar
  15. Schiff JD, Li PS, Goldstein M: Correlation of ultrasonographic and orchidometer measurements of testis volume in adults. BJU Int. 2004, 93: 1015-1017. 10.1111/j.1464-410X.2003.04772.x.View ArticlePubMedGoogle Scholar
  16. Mitchell V, Robin G, Boitrelle F, Massart P, Marchetti C, Marcelli F, Rigot JM: Correlation between testicular sperm extraction outcomes and clinical, endocrine and testicular histology parameters in 120 azoospermic men with normal serum FSH levels. Int J Androl. 2011, 34: 299-305. 10.1111/j.1365-2605.2010.01094.x.View ArticlePubMedGoogle Scholar
  17. Andersson A-M, Petersen JH, Jørgensen N, Jensen TK, Skakkebaek NE: Serum inhibin B and follicle-stimulating hormone levels as tools in the evaluation of infertile men: significance of adequate reference values from proven fertile men. J Clin Endocrinol Metab. 2004, 89: 2873-2879. 10.1210/jc.2003-032148.View ArticlePubMedGoogle Scholar
  18. Tauber R, Johnsen N: Antegrade scrotal sclerotherapy for the treatment of varicocele: technique and late results. J Urol. 1994, 151: 386-390.PubMedGoogle Scholar
  19. Nabi G, Asterlings S, Greene DR, Marsh RL: Percutaneous embolization of varicoceles: outcomes and correlation of semen improvement with pregnancy. Urology. 2004, 63: 359-363. 10.1016/j.urology.2003.09.026.View ArticlePubMedGoogle Scholar
  20. Czyglik F, David G, Bisson JP, Jouannet P, Gernigon C: Teratospermia in varicocele. Nouv Presse Médicale. 1973, 2: 1127-1130.Google Scholar
  21. Osawa Y, Sueoka K, Iwata S, Shinohara M, Kobayashi N, Kuji N, Yoshimura Y: Assessment of the dominant abnormal form is useful for predicting the outcome of intracytoplasmic sperm injection in the case of severe teratozoospermia. J Assist Reprod Genet. 1999, 16: 436-442. 10.1023/A:1020573609836.PubMed CentralView ArticlePubMedGoogle Scholar
  22. World Health Organization: The influence of varicocele on parameters of fertility in a large group of men presenting to infertility clinics. Fertil Steril. 1992, 57: 1289-1293.Google Scholar
  23. Benoff S, Marmar JL, Hurley IR: Molecular and other predictors for infertility in patients with varicoceles. Front Biosci J Virtual Libr. 2009, 14: 3641-3672.Google Scholar
  24. McIntyre M, Hsieh T-C, Lipshultz L: Varicocele repair in the era of modern assisted reproductive techniques. Curr Opin Urol. 2012, 22: 517-520. 10.1097/MOU.0b013e328358e191.View ArticlePubMedGoogle Scholar
  25. Chan P: Management options of varicoceles. Indian J Urol IJU J Urol Soc India. 2011, 27: 65-73. 10.4103/0970-1591.78431.View ArticleGoogle Scholar
  26. Will MA, Swain J, Fode M, Sonksen J, Christman GM, Ohl D: The great debate: varicocele treatment and impact on fertility. Fertil Steril. 2011, 95: 841-852. 10.1016/j.fertnstert.2011.01.002.PubMed CentralView ArticlePubMedGoogle Scholar
  27. Dewire DM, Thomas AJ, Falk RM, Geisinger MA, Lammert GK: Clinical outcome and cost comparison of percutaneous embolization and surgical ligation of varicocele. J Androl. 1994, 15 (Suppl): 38S-42S.PubMedGoogle Scholar
  28. Sathya Srini V, Belur Veerachari S: Does varicocelectomy improve gonadal function in men with hypogonadism and infertility? Analysis of a prospective study. Int J Endocrinol. 2011, 2011: 916380-PubMed CentralView ArticlePubMedGoogle Scholar
  29. Fisch H, Hyun G: Varicocele repair for low testosterone. Curr Opin Urol. 2012, 22: 495-498. 10.1097/MOU.0b013e328358e0fb.View ArticlePubMedGoogle Scholar
  30. Ozden C, Ozdal OL, Bulut S, Guzel O, Koyuncu HH, Memis A: Effect of varicocelectomy on serum inhibin B levels in infertile patients with varicocele. Scand J Urol Nephrol. 2008, 42: 441-443. 10.1080/00365590802028141.View ArticlePubMedGoogle Scholar
  31. Sakamoto H, Saito K, Ogawa Y, Yoshida H: Effects of varicocele repair in adults on ultrasonographically determined testicular volume and on semen profile. Urology. 2008, 71: 485-489. 10.1016/j.urology.2007.11.040.View ArticlePubMedGoogle Scholar
  32. Sakamoto H, Ogawa Y, Yoshida H: Relationship between testicular volume and varicocele in patients with infertility. Urology. 2008, 71: 104-109. 10.1016/j.urology.2007.08.019.View ArticlePubMedGoogle Scholar

Copyright

© Prasivoravong et al.; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement